Clinical Trial Update: Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

View source ↗

Summary

A clinical trial is planned to screen for hyperuricemia in patients with metabolic-associated fatty liver disease (MAFLD); recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Metabolic-associated Fatty Liver Disease

Snippet

Sponsor: Assiut University | Conditions: Hyperuricemia and MAFLD | Status: NOT_YET_RECRUITING